Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,338 | 6,262 | 303 | 543 | N/A |
| TOTAL | $12,715 | $6,533 | $306 | $545 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 124 | 54 | N/A | N/A | N/A |
| Other Non-Current Assets | 36 | 14 | 0 | 0 | 0 |
| TOTAL | $161 | $68 | $N/A | $N/A | $N/A |
| Total Assets | $12,875 | $6,601 | $306 | $545 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 162 | 144 | 307 | 162 | N/A |
| Accounts payable and accrued liabilities | 1,314 | 344 | 182 | 50 | 0 |
| Accrued Expenses | 562 | 250 | 64 | 30 | N/A |
| Other current liabilities | N/A | N/A | 20 | N/A | N/A |
| TOTAL | $3,630 | $738 | $649 | $277 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 331 | 467 | N/A |
| Deferred Revenues | 1,591 | N/A | N/A | N/A | N/A |
| TOTAL | $260 | $N/A | $331 | $467 | $N/A |
| Total Liabilities | $3,890 | $738 | $980 | $743 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,252 | 864 | N/A | N/A | N/A |
| Common Shares | 4 | 3 | 1 | 1 | N/A |
| Retained earnings | -13,278 | -4,427 | -1,887 | -1,284 | N/A |
| TOTAL | $8,985 | $5,863 | $-675 | $-198 | $N/A |
| Total Liabilities And Equity | $12,875 | $6,601 | $306 | $545 | $0 |